Australia's 3rd Largest Economy

Member News

  • 18-Nov-2020 12:13 | Tracy Dawson (Administrator)

    Are you looking for a unique way to celebrate the end of 2020?

    The William Inglis Hotel is hosting Christmas Markets in their Riverside Stables, offering the perfect place to send off the year and welcome the magic of Christmas.

    They are excited to invite you along with your family, friends or colleagues to their inaugural event, taking place 17-20th December 2020.

    The Riverside Stables Christmas Markets is a family & pet friendly event featuring markets stalls, live carols and Christmas lights.

    Grab a bite to eat, sip on a glass of bubbles and browse through the 40+ vendors showcasing handmade gifts, arts, fashion and homewares – ideal for any last minute shoppers!

    The William Inglis Hotel hope you can join them in supporting local small businesses and creating memorable moments.

    Click here for tickets

    The William Inglis Hotels is an ALLSAFE property and this is a Covid-Safe event. Tickets have been split across multiple sessions to monitor venue capacity and adhere to our CovidSafe plan.

  • 18-Nov-2020 09:55 | Tracy Dawson (Administrator)

    A gene therapy for Cystic Fibrosis (CF) could undergo development in the laboratory within three years, thanks to Cure4 Cystic Fibrosis Foundation (Cure4CF), who in partnership with the National Foundation for Medical Research and Innovation (NFMRI) have awarded a grant to a team at Children’s Medical Research Institute (CMRI) through the NFMRI scheme.

    The $140,000 Barbara Stow-Smith Cure4 Cystic Fibrosis Innovation grant was awarded to a team of medical researchers from the University of Sydney’s Faculty of Medicine and Health who are all based at Westmead. The project will be led by Dr Leszek Lisowski from Children’s Medical Research Institute who is the Head of the Translational Vectorology Unit and Professor Hiran Selvadurai who is Senior Staff Specialist in Paediatric Respiratory Medicine at The Children’s Hospital at Westmead. It will also involve Dr Predag Kalajdzic from CMRI’s Vector and Genome Engineering Facility (VGEF), and two PhD students Adrian Westhaus and Kimberley Dilworth from CMRI.

    The project aims to develop new vector-based gene therapy tools for the treatment of Cystic Fibrosis. Dr Lisowski creates microscopic delivery vehicles, called vectors, which make gene therapies possible. The vectors deliver gene therapeutics into the patient’s cells affected by the disease. The therapy adds a working copy of the faulty gene or replaces the faulty gene with a functional version.

    As part of the project Dr Lisowski’s team will also work to develop a novel preclinical model of human lung that will enable studies not only of potential treatments for CF but also other conditions such as asthma and other lung diseases.

    A gene therapy treatment like the one Dr Lisowski is working to develop has the potential to extend the life expectancy and improve quality of life for over 10,000 mostly young patients in Australia living with CF.

    “Our approach has the potential to alleviate the lung-associated complications of CF, which have major health implications and are usually the most difficult to treat,’’ Dr Lisowski said.

    “We are very excited to start this project in an endeavour to help children suffering with CF, and so grateful to for making this possible.’’

    Senior Staff Specialist in Paediatric Respiratory Medicine at The Children’s Hospital at Westmead, Professor Hiran Selvadurai, says he is excited about the prospect of a gene therapy cure for CF patients.

    “This grant gives us an opportunity to make a difference to sick children. We are excited to embark on this journey in order to bring real hope for children with CF,” said Professor Selvadurai.

    Cure4 Cystic Fibrosis Executive Manager Suzy Dimaline said they were thrilled to partner with Dr Lisowski and his team at CMRI. “We are incredibly excited to fund this research, a gene therapy treatment would be game-changing for our cystic fibrosis community, not only here in Australia, but also across the globe.’’

    Cassie Jones knows all about this suffering. Her son Charlie, who is only five, takes 20 pills a day and needs medicine every time he eats plus physiotherapy and use of a nebulizer every day.

    “Gene therapy eventually aims to cure, not just treat, cystic fibrosis, and the beauty of this is that it could work for anyone with CF, no matter what their mutations are,’’ Ms Jones said.

    “This is so important in CF because there are so many different mutations, and more so for us as Charlie carries a rarer one that makes current break-through medications ineffective.

    “We work hard to keep Charlie as healthy as possible because we’re waiting for the day that treatments like this will prevent further damage to his body and add years to his life. News like this just brings that day closer and within reach.’’

    The Cystic Fibrosis gene is carried by 1 in 25 Australians. Around 100 newborns in Australia are diagnosed each year with the disease.

    To donate to CMRI click here.

  • 18-Nov-2020 09:30 | Tracy Dawson (Administrator)

    This is usually the time of year that energy markets brace for peak energy demand associated with higher consumption over the summer months. This, and the wave of contract renewals that fall due at the end of each December, typically converge to place upward pressure on energy prices and drive volatility.

    However, as we know, 2020 is different from previous years. We have seen the COVID-19 pandemic change the nature of energy demand amid temporary business shutdowns and an exodus of people from offices and worksites as they worked from home. Essentially, the pandemic lifted residential energy use as it constrained commercial and industrial use, with overall demand declining.

    Over the course of 2020, we have seen electricity prices continuing their downward trajectory that started from its peak in mid-2017, reaching levels that we believe to be at or near the bottom of the current pricing cycle. In recent months we have seen wholesale electricity prices continue to trade sideways in the absence of clear direction on demand levels that will remain opaque until the economy emerges from the pandemic.

    The sideways price movements are a function of both supply and demand-side forces acting to keep a cap on prices. Production costs remaining at or near the cost of generation curtailing prices, and current demand levels are influenced by reduced economic activity, the expected limited short-term growth in renewable capacity and increasing roof-top solar capacity.

    As a result, far more businesses than previous years have already brought forward their energy contract renewals to take advantage of the lower price environment. This means that fewer businesses will be vying for contracts in the lead up to December 31, reshaping the extent of the typical ‘renewals cliff’.

    However, electricity demand will rise over the summer peak demand period, which will lift prices, even if, amid reduced overall demand, there is less price volatility this summer compared to recent years. In fact, AEMO has indicated in a recent report that the reliability outlook has improved for this summer.

    As businesses have moved quickly to lock in lower prices, we have also seen contract lengths extending with most businesses renewing contracts out to 2023 and in some cases, 2024. Again, businesses are taking advantage of the current point in the pricing cycle to lock in lower prices over the long-term, ahead of the economic recovery and the likelihood of steadily increasing demand.

    Our outlook remains that both wholesale and retail prices will remain generally steady until greater economic certainty returns, notwithstanding seasonal fluctuations. And amid the continued lower price environment and with demand set to increase over summer, there is a substantial opportunity for those who are yet to renew contracts to do so while conditions remain favourable.

    Energy Action specialises in achieving significant cost savings and has helped businesses save thousands on their energy bills. If you would like to discuss how you can save energy and reduce costs over summer, call 1300 553 551 or visit

  • 17-Nov-2020 16:47 | Tracy Dawson (Administrator)

    By Professor Philip O’Connell, Executive Director, The Westmead Institute for Medical Research

    Recent weeks have seen new cases of COVID-19 steadily drop across most of Australia, and reports of promising COVID-19 vaccine trials are being cautiously welcomed. While 2020 has been a challenging year for so many, both personally and professionally, it seems that the early, decisive and committed approach taken across Australia to stop the spread of COVID-19 has proven successful.

    However, we now watch as a very different situation continues to unfold in the United States and parts of Europe, and this should act as a warning. We cannot be complacent. A vaccine is still some way off, and continued vigilance is vital.

    Australia’s success to date is primarily due to its world-leading contact tracing capabilities and its public health response. I am proud to say that The Westmead Institute for Medical Research (WIMR) has been at the forefront of Australia’s COVID-19 research efforts, and continues to play significant leadership roles in these areas.

    WIMR is a multi-disciplinary institute, and is home to some of Australia’s brightest, and most talented researchers. This expertise and commitment means that WIMR has been able to pivot quickly, and take a leadership role in Australia’s response to the COVID-19 pandemic.

    Contact tracing remains a strong defence against COVID-19, and was especially vital in the first weeks and months of this pandemic. Very early on, a team at WIMR adapted its existing, unique genome sequencing method to specifically target COVID-19. They worked with the public health service to analyse and trace the origins of the first wave of cases and how they evolve over time and from site to site. I am proud to say that this sequencing method is now being used across Australia and the world.

    Another WIMR research team who, before the pandemic, were focused on infectious diseases like influenza and sepsis, are now using their experience to develop a COVID-19 blood test. This test would rapidly identify which COVID-19 patients would need to be admitted to hospital for urgent medical treatment, rather than being able to self-isolate or quarantine at home.

    A team of globally recognised virologists are using expertise gained in areas such as HIV and shingles to develop a COVID-19 vaccine. Their focus is to develop a vaccine specifically targeted to some of the most vulnerable members of our community – the ageing.

    WIMR has initiated a series of events, aimed at business leaders, to provide the most up-to-date information about COVID-19 from reputable and informed sources. The WIMR Director’s Series will feature WIMR’s researchers, as well as respected business leaders, discussing COVID-19. They will unpack the facts and offer insights into the current and potential future impact of this pandemic.

    To register your interest in attending one of the WIMR Director’s Series events, please contact Katrina Dowling, CEO of the WIMR Foundation at; or Amanda Thompson, Strategic Partnerships Manager at; or phone 02 8627 3000.

  • 17-Nov-2020 15:49 | Tracy Dawson (Administrator)

    Deloitte Access Economics has been a leader in shaping reform debates over many decades. Now we bring our expertise to the wicked problem of climate change – and the economics of it. This topic has been the subject of debate, misconstruction, and genuine complexity.

    At the core of the issue on climate change is the assumption that unconstrained emissions (and therefore warming) are compatible with economies which can grow forever. But, based on the science, this is not possible. Yet this has been the benchmark of economic analysis and the basis for assessment of any actions to solve for climate change.

    Deloitte Access Economics has constructed a view of the Australian economy where inaction, or mis-action, in preventing climate change causes damage to the Australian economy. Climate change is no longer a scenario, but instead becomes the baseline for the economy.

    While inaction will have the effect of curtailing Australia’s economic growth to the tune of $3.4 trillion and 880,000 fewer jobs in just 50 years, there is an upside – a new choice that Australia can make to create a new climate for growth. And the payoff? A bigger economy –$680 billion bigger – with 250,000 more jobs in just 50 years. Download the report

  • 17-Nov-2020 15:25 | Tracy Dawson (Administrator)

    By Matthews Folbigg Lawyers

    Caveats are a powerful tool to protect interests in land. When debt recovery is difficult (say for instance because of a COVID-19 moratorium on certain debt recovery actions) having a secured interest in property can be a significant advantage to creditors. But getting the caveatable interest wrong may end up with proceedings in the High Court of Australia and significant legal expenses and the risk of damages to the land owner. This was what faced a trustee in bankrupt in the High Court’s decision in Boensch v Pascoe (2019) 94 ALJR 112 (“Boensch”).

    A simple Caveat

    In the case of Boensch, Mr Boensch became bankrupt in August 2005. His trustee in bankruptcy identified a property in Mr Boensch’s name (“the Property”), and lodged a caveat.

    However, although the Property was registered in his name, it was held by Mr Boensch on trust for his children. He did not have any interest in the land which the Trustee could take. Although the Trustee challenged the existence of the trust, the issue was resolved in favour of Mr Boensch.

    A “Reasonable Cause”

    Mr Boensch then commenced proceedings against the Trustee seeking compensation for loss he alleged the Trust had suffered by reason of the caveat being recorded on the title to the Property.

    A critical question was whether the caveat had been lodged without “reasonable cause” (s 74P(1) of the Real Property Act 1900 (NSW)).

    The Full Federal Court held that Mr Boensch’s legal interest had vested in the Trustee and was enough to justify the Trustee lodging a caveat.

    The High Court thought this went too far. In the absence of a substantive or beneficial interest in the Property, there was no caveatable interest. However, after consideration of the complicated history of trusts and insolvency the High Court found that there may have been a right of indemnity which belonged to Mr Boensch which would have vested in the Trustee in Bankruptcy and supported the caveat. This right of indemnity and the Trustee’s ‘honest belief on reasonable grounds’ that the Property had vested in him, meant no damages were payable.

    A word of warning

    Whilst the Trustee in Bankruptcy was ultimately successful in avoiding liability, it took several years and a High Court case to finalise the matter. The bankrupt has since become bankrupt a second time, and it might be considered doubtful whether the Trustee’s costs may be recovered. Lodging a caveat is one of the most effective ways of preventing a disposition of a debtor’s real property, but must be supported by a proper equitable interest in land and in the absence of legal advice about that interest, may lead to significant unrecoverable legal costs, and claims for even more significant damages for a wrongly lodged caveat.

    If you would like more information or advice about the lodgement of caveats, please contact:

    Stephen Mullette

    P: (02) 9806 7459



    Jeffrey Brown

    P: (02) 9806 7446


  • 12-Nov-2020 16:31 | Tracy Dawson (Administrator)

  • 11-Nov-2020 17:16 | Tracy Dawson (Administrator)

    By Blacktown City Council

    There is sufficient evidence from government agencies and research bodies, indicating that the future socio-economic environment across Australia will change as a result of the current COVID-19 pandemic.

    The damage caused by the pandemic will ripple down through the national and state economies and have the greatest impact at the local level.

    Central City district

    As a result, Blacktown City, Cumberland City, Parramatta City, and The Hills Councils are looking to plan for the post-pandemic environment in their sub-region of western Sydney. These councils constitute the area designated as the Central City district by the Greater Sydney Commission.

    The councils believe this initiative adds value to and informs the current and future work of the Commission.

    Extract from the Greater Sydney Commission’s Structure plan for the Central City district May 2018

    Research objectives

    The 4 councils are managing a research study which will identify the likely effects of the pandemic on our sub-regional economy over the next decade. Such a study will be published and communicated to their local business communities. The results of the study will:

    • help the business community plan for the post pandemic environment and make whatever changes they need to their business activities and direction, for their future prosperity.
    • assist the councils in the future planning and delivery of services to their communities.

    Our team

    The councils very much welcome Westpac Banking Corporation as part of their team. Westpac is the financial sponsor to this research, and providing important contributions to the direction and scope of this project.

    The councils also welcome the Australian Catholic University, which will provide oversight and peer review of the research being undertaken.

    The study

    Western Sydney University have been engaged to carry out this project. Their research team, headed by Dr Kathy Tannous, will undertake a literature search review and interview representatives from a range of organisations across the district. From this evidence, they will create scenario-planning modelling which will identify plausible developments over the next decade across the following areas:

    • future levels of immigration
    • household and business debt levels
    • unemployment impacts
    • housing affordability
    • people movement
    • international travel and transport
    • population mobility, and
    • shifts in scope, timescale and intensity of the overall development in the sub-region.

    Outputs and outcomes

    The project is intended to deliver the following results:

    • a peer-reviewed study, in report format, identifying a socio-economic road map ahead for the sub-regional western Sydney economy.
    • inform the Central City district business communities of the likely economic options emerging in the period ahead.
    • provide local businesses with the insights to review their business models and plan the future direction for their operations.
    • guide the councils in the strategic and community planning of the future delivery of services to their communities in the period ahead.
    • promote the sense that the councils and corporate sponsor are providing key leadership and direction for our local economies.
  • 11-Nov-2020 14:20 | Tracy Dawson (Administrator)

    Global events like coronavirus present new challenges, daily. For those working in new ways, and in new environments, it’s important to consider how to maintain productivity under pressure.

    Read more here

    Macquarie has been providing Business Banking solutions for over 30 years and provides SME clients with tools and strategies to grow and develop their business. You can get regular updates by subscribing to the monthly newsletter, Strictly Business by visiting If you would like to find out more about how Macquarie can support you to take your business further, call Sam McCarthy at our Parramatta office on 0417 518 724 and be connected with one of our banking specialists.

    This information has been prepared by Macquarie Bank Limited ABN 46 008 583 542 AFSL and Australian Credit Licence 237502 (“Macquarie”) for general information purposes only. This information does not constitute advice. Opinions expressed are subject to change without notice. No member of Macquarie accepts any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this information.

  • 10-Nov-2020 15:06 | Tracy Dawson (Administrator)

    William Buck's Jumpstart Series is a podcast geared towards startups, scaleups and anyone interested in the Tech industry. Episodes are bite-sized (no more than 15 minutes long) and focused on providing actionable lessons for founders to implement right after listening.

    Hosts, Jack Qi, Director, Technology Tax, Mark Calvetti, Director, Corporate Advisory and Nick Kenny, Director, Business Advisory, don’t sugar-coat it when it comes to growing your business. Each specialist shares their own unique views on the trending topics and biggest learnings they’ve seen in the industry and the banter between them is fantastic.

    Sitting down with investors, founders and experts, they dive into the factors that matter most to startups and scaleups and question what works and what doesn’t. They talk about how some of the best tech companies got to where they are and uncover the financial strategies to successfully scale a tech company.

    Taking a different spin to others, they’re determined to break the accountant stereotype and bring you a technical podcast with personality. If you’re looking for an Australian podcast that discusses the realities of managing businesses finances, then the Jumpstart series should be on your list.

    The Jumpstart Series is available on Spotify, Google & Apple. Click here to find out more or to begin listening.   

Powered by Wild Apricot Membership Software